NCT06710353 The Effect of Preoperative Albumin Administration on Postoperative Acute Kidney Injury in Pediatric Patients With Hypoalbuminemia Undergoing Cardiac Surgery
| NCT ID | NCT06710353 |
| Status | Recruiting |
| Phase | — |
| Sponsor | Seoul National University Hospital |
| Condition | Acute Kidney Injury |
| Study Type | INTERVENTIONAL |
| Enrollment | 190 participants |
| Start Date | 2025-01-09 |
| Primary Completion | 2027-12-31 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.
This trial targets 190 participants in total. It began in 2025-01-09 with a primary completion date of 2027-12-31.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
The study aims to evaluate whether preoperative albumin supplementation in pediatric patients with hypoalbuminemia undergoing cardiac surgery can reduce inflammatory responses and prevent acute kidney injury (AKI) following cardiopulmonary bypass.
Eligibility Criteria
Inclusion Criteria: * Pediatric patients under 7 years of age undergoing cardiac surgery with cardiopulmonary bypass * Preoperative serum albumin level of 4.0 g/dL or lower Exclusion Criteria: * abnormal preoperative creatinine level * history of dialysis * liver dysfunction * diabetes * history of hypersensitivity to albumin * coagulation disorders
Contact & Investigator
Frequently Asked Questions
Who can join the NCT06710353 clinical trial?
This trial is open to participants of all sexes, up to 7 Years, studying Acute Kidney Injury. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT06710353 currently recruiting?
Yes, NCT06710353 is actively recruiting participants. Contact the research team at muslab6@snu.ac.kr for enrollment information.
Where is the NCT06710353 trial being conducted?
This trial is being conducted at Seoul, South Korea.
Who is sponsoring the NCT06710353 clinical trial?
NCT06710353 is sponsored by Seoul National University Hospital. The trial plans to enroll 190 participants.
Related Trials
Related Intelligence Guides
In-depth guides covering this condition's trials, eligibility, and what to expect.